Angela Punnett

Also affiliated with Hospital for Sick Children, SickKids Foundation

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.208Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013

Top 65%

0.208DataRank

Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Papers

Driven by 12 papers — median percentile 35. Top paper: “Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma”.

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

New England Journal of Medicine(2022)10.1056/nejmoa2206660

N/A

3.7DataRank · unranked

170 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Terzah M. Horton +10 more

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2405888

N/A

3.4DataRank · unranked

211 citations

Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens +42 more

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Hematological Oncology(2023)10.1002/hon.3163_5

N/A

0.464DataRank · unranked

21 citations

Michael LeBlanc, Sharon M. Castellino, Huilin Li, Sarah C. Rutherford, Andrew M. Evens +41 more

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013

Top 65%

0.208DataRank

Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3876

N/A

0DataRank · unranked

6 citations

Raymond B. Mailhot Vega, Lindsay A. Renfro, Qinglin Pei, Anne-Marie Charpentier, Rahul R. Parikh +15 more

127 | HEALTH‐RELATED QUALITY OF LIFE (HRQoL) ENDPOINTS OF THE PHASE III INTERGROUP S1826 ADVANCED‐STAGE, CLASSIC HODGKIN LYMPHOMA (cHL) TRIAL

Hematological Oncology(2025)10.1002/hon.70093_127

N/A

0DataRank · unranked

1 citations

H. Li, Alex F. Herrera, Kelly Davison, Sharon M. Castellino, Hildy Dillon +11 more

Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331

Pediatric Blood & Cancer(2025)10.1002/pbc.31856

N/A

0DataRank · unranked

1 citations

Lindsay A. Renfro, Frank G. Keller, David Hodgson, Angela Punnett, Kathleen M. McCarten +6 more

An intergroup collaboration for advanced stage classical Hodgkin lymphoma (cHL) in adolescents and young adults (AYA): SWOG S1826.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps8067

N/A

0DataRank · unranked

8 citations

Michael LeBlanc, Alex F. Herrera, Susan K. Parsons, Angela Punnett, David Hodgson +8 more

Group-based trajectories of health-related quality of life among pediatric patients with high-risk Hodgkin lymphoma

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf197

N/A

0DataRank · unranked

0 citations

Angie Mae Rodday, Lindsay A. Renfro, Yue Wu, Tara O. Henderson, Frank G. Keller +6 more

Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7504

N/A

0DataRank · unranked

5 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Angela Punnett +9 more

PATTERNS OF PRESENTATION AND OUTCOMES IN STAGE IV HODGKIN LYMPHOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (COG) AHOD1331 TRIAL

Hematological Oncology(2023)10.1002/hon.3163_34

N/A

0DataRank · unranked

1 citations

Kathleen M. McCarten, Qinglin Pei, Sarah A. Milgrom, Joseph L. Belsky, S. Cho +6 more

Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma

JCO Oncology Practice(2024)10.1200/op.24.00089

N/A

0DataRank · unranked

7 citations

Susan K. Parsons, Frank G. Keller, Lindsay A. Renfro, Qinglin Pei, Angie Mae Rodday +7 more

Angela Punnett

Indexed papers

Top data-sharing exemplar

Papers